“According to my calculations, a domestic drug for the treatment of spinal muscular atrophy may appear on the market as early as 2025-2026,” he said in an interview with Izvestia.
Kutsev said that the Russian drug for the treatment of SMA was developed by Biocad, and is currently undergoing clinical trials.
Earlier it became known that the drug "Zolgensma" used to treat spinal muscular atrophy officially appeared in Russia.
The Commissioner for Children's Rights in Tatarstan, Irina Volynets, in an interview with RT, commented on the official appearance in Russia of the drug Zolgensma for the treatment of spinal muscular atrophy.